Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Contrast Media × Gastrointestinal × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4 Genitourinary 3 Thoracic 2 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gastrointestinal 1 Endocrine 1 Breast 1

Conditions

Pancreatic Ductal Adenocarcinoma 1

Interventions

Oxaliplatin 122 Fluorouracil 119 Bevacizumab 95 pembrolizumab 92 Leucovorin 89 Specimen Handling 84 Gemcitabine 81 Capecitabine 76 Magnetic Resonance Spectroscopy 69 Irinotecan 66 Cisplatin 54 Nivolumab 53 Cetuximab 52 Biopsy 51 durvalumab 49 130-nm albumin-bound paclitaxel 41 atezolizumab 37 Drug Therapy 37 Paclitaxel 35 Radiotherapy 29 Folfox protocol 29 Taxes 28 Carboplatin 27 Albumin-Bound Paclitaxel 27 regorafenib 26 dehydroftorafur 25 Cyclophosphamide 23 tislelizumab 22 Trastuzumab 22 fludarabine 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07324096 2026-03-19

AI-PACED

Mayo Clinic

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡